{"schema_version":"secwatch.filing_event.v1","accession":"0001087294-26-000068","form_type":"8-K/A","ticker":"CPIX","cik":"0001087294","company_name":"CUMBERLAND PHARMACEUTICALS INC","filed_at":"2026-09-11T20:51:49+00:00","discovered_at":"2026-09-11T20:53:16.303556+00:00","generated_at":"2026-09-11T20:53:19.373666+00:00","sec_items":["5.07"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"confidence":"high","headline":"Cumberland to hold say-on-pay votes every 3 years after shareholder preference","bullets":["Shareholders at April 21, 2026 annual meeting favored triennial advisory votes on executive compensation.","Board determined advisory compensation votes will occur every three years until next frequency vote.","Company must hold another frequency advisory vote within six years per SEC requirement.","Original 8-K filed April 24, 2026; this amendment updates Item 5.07 disclosures."],"urls":{"canonical":"https://secwatch.observer/filing/0001087294-26-000068","json":"https://secwatch.observer/filing/0001087294-26-000068.json","markdown":"https://secwatch.observer/filing/0001087294-26-000068.md","text":"https://secwatch.observer/filing/0001087294-26-000068.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000068/0001087294-26-000068-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1087294/000108729426000068/cpix-20260421.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-09-11T20:53:19.373666+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}